Emerald Health Therapeutics, Inc. (EMHTF) Research

Emerald Health Therapeutics, Inc. (EMHTF) is a Canadian entity engaged in the cultivation, distribution, and sale of cannabis for both recreational and medical markets throughout Canada. The company offers a wide range of cannabis products, including dried flower, pre-rolls, oral sprays, advanced nano emulsion beverages, and various cannabis oil formulations. These products are marketed under distinct brands such as SYNC Wellness, fuse, Emerald, and Souvenir. Initially founded as T-Bird Pharma Inc., the organization rebranded to Emerald Health Therapeutics, Inc. in June 2015. Headquartered in Vancouver, Canada, Emerald Health Therapeutics, Inc. has been operating as a subsidiary of Skye Bioscience, Inc. since November 10, 2022.

Market snapshot

Symbol
EMHTF
Price
$0.04
Day change
+55.17%
Market cap
$11.2M
P/E ratio
-0.28x
52-week range
0.02-0.0681
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Peer companies

  • Bionomics Limited (BNOEF)
  • RIV Capital Inc. (CNPOF)
  • The Flowr Corporation (FLWPF)
  • HealthBeacon plc (HBCNF)
  • Immune Therapeutics, Inc. (IMUN)
  • MGC Pharmaceuticals Limited (MGCLF)
  • MDxHealth S.A. (MXDHF)
  • Tetra Bio-Pharma Inc. (TBPMF)

Open Emerald Health Therapeutics, Inc. (EMHTF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.